Sonova Holding Ltd.

SOON

Equity

ISIN CH0012549785 / Valor 1254978

SIX Swiss Exchange (2024-09-17)

CHF 301.90-0.53%

Sonova Holding Ltd.
UMushroom community rating:

0.00 0 votes No rating yet

NegativeNeutralPositive

About company

Sonova Holding Ltd. is a global leader in innovative hearing care solutions, offering a wide range of products and services such as personal audio devices, wireless communication systems, hearing aids, and cochlear implants. Founded in 1947 and headquartered in Stäfa, Switzerland, Sonova operates through four main businesses - Hearing Instruments, Audiological Care, Consumer Hearing, and Cochlear Implants - under core brands like Phonak, Unitron, AudioNova, Sennheiser (under license), and Advanced Bionics, as well as recognized regional brands. With globally diversified sales and distribution channels, Sonova serves a growing consumer base in over 100 countries.

Summarized from source with an LLMView SourceSector: Healthcare

Revenue Growth

In the second quarter of the 2023/24 financial year, Sonova Holding Ltd. reported a revenue increase of 3.2% in local currencies, reaching CHF 3,738.4 million. This growth was driven by the continued expansion of their audiological care network and strong performance in key markets such as Germany, the UK, Belgium, and the Netherlands.

Gross Profit

Sonova Holding Ltd.'s gross profit for Q2 2023/24 amounted to CHF 2,610.4 million. Adjusted gross profit saw a 6.3% increase in local currencies but a slight decline of 0.9% in Swiss francs, totaling CHF 2,621.5 million. This was supported by prior year price increases and efficiency gains in operations.

Operating Profit

Reported operating profit (EBIT) for Sonova Holding Ltd. in Q2 2023/24 was CHF 669.9 million, down 10.3% in Swiss francs. Adjusted EBITA reached CHF 771.4 million, reflecting a 4.4% increase in local currencies but an 8.2% decline in Swiss francs. The adjusted EBITA margin was 21.3%, slightly down from the previous year.

Earnings Per Share

Sonova Holding Ltd. reported basic earnings per share (EPS) of CHF 10.08 for Q2 2023/24, which represents a 10.0% increase in local currencies but a 6.3% decrease in Swiss francs. Adjusted EPS was CHF 10.06, up 6.4% in local currencies but down 9.6% in Swiss francs compared to the prior year.

Segment Performance

The Hearing Instruments segment of Sonova Holding Ltd. generated sales of CHF 3,347.9 million in Q2 2023/24, marking a 3.2% increase in local currencies but a 3.0% decline in Swiss francs. The Audiological Care business saw a 9.2% increase in local currencies, driven by strong growth in European markets and acquisitions, including HYSOUND in China.

Summarized from source with an LLMView Source

Key figures

34.7%1Y

-20.4%3Y

38.6%5Y

Performance

24.1%1Y

31.5%3Y

32.2%5Y

Volatility